Accessibility Menu
 
Silo Pharma logo

Silo Pharma

(NASDAQ) SILO

Current Price$0.36
Market Cap$5.10M
Since IPO (2014)-100%
5 Year-98%
1 Year-69%
1 Month-2%

Silo Pharma Financials at a Glance

Market Cap

$5.10M

Revenue (TTM)

$72.10K

Net Income (TTM)

$4.23M

EPS (TTM)

$-0.61

P/E Ratio

-0.59

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$0.36

Volume

21

Open

$0.34

Previous Close

$0.36

Daily Range

$0.34 - $0.37

52-Week Range

$0.22 - $1.21

SILO News

No articles available.

SILO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Silo Pharma

Industry

Biotechnology

Employees

3

CEO

Eric Weisblum

Headquarters

Sarasota, FL 34236, US

SILO Financials

Key Financial Metrics (TTM)

Gross Margin

-6%

Operating Margin

-59%

Net Income Margin

-59%

Return on Equity

-75%

Return on Capital

10%

Return on Assets

-19%

Earnings Yield

-1.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.10M

Shares Outstanding

14.17M

Volume

21

Short Interest

0.00%

Avg. Volume

955.98K

Financials (TTM)

Gross Profit

$813.96K

Operating Income

$4.28M

EBITDA

$4.28M

Operating Cash Flow

$4.66M

Capital Expenditure

$0.00

Free Cash Flow

$4.66M

Cash & ST Invst.

$6.86M

Total Debt

$0.00

Silo Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$18.03K

+0.0%

Gross Profit

$235.02K

+38.5%

Gross Margin

-13.04%

N/A

Market Cap

$5.10M

N/A

Market Cap/Employee

$1.70M

N/A

Employees

3

N/A

Net Income

$881.53K

+49.1%

EBITDA

$783.59K

+56.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$6.86M

-3.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-19.45%

N/A

Return on Invested Capital

9.89%

N/A

Free Cash Flow

$780.28K

+14.9%

Operating Cash Flow

$780.28K

+14.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TTNPTitan Pharmaceuticals, Inc.
$2.34-11.36%
CANFCan-Fite BioPharma Ltd.
$3.10+2.99%
CNSPCNS Pharmaceuticals, Inc.
$2.39+5.29%
INMInMed Pharmaceuticals Inc.
$0.64+4.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15+0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$80.49-0.10%
IBITiShares Bitcoin Trust
$38.42+0.02%

Questions About SILO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.